Collateral Therapeutics Pages on BioPortfolio:

BioPortfolio - Biocorporate Search Gene Therapy1
Collateral Therapeutics Incorporated. Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance ...
http://www.bioportfolio.com/biocorporate/Gene%20Therapy-comp...

NASDAQ Biotechnology Companies - Barr - Dynacare
CIPH · CIPHERGEN BIOSYSTEMS INC, Nasdaq, Biotech. CBZ, COBALT CORP, NYSE, Services to Med Profs. CLTX · COLLATERAL THERAPEUTICS INC, Nasdaq, Biotech ...
http://www.bioportfolio.com/nasdaq/nasdaq_barr_dynacare.htm...

BioPortfolio - Accentia BioPharmaceuticals - Profile
specialty pharmaceuticals and biologics for targeted therapeutics. ... undesirable collateral damage (i.e. toxicity), while boosting efficacy. ...
http://www.bioportfolio.com/biocorporate/30827-Accentia+BioP...

Progress in the treatment of peripheral arterial disease (PAD)
Novel therapeutics are being developed for the treatment of PAD: There are ... growth factors to induce the development of new collateral blood vessels. ...
http://www.bioportfolio.com/news/DailyUpdates_72.htm...

BioPortfolio - Blood Circulation - InDepth
New Patterns of Retinal Collateral Circulation are Exposed by the Retinal ... to von Willebrand Factor and their use as thrombotic disease therapeutics ...
http://www.bioportfolio.com/indepth/Blood_Circulation.pdf...

BioPortfolio - Coronary Circulation - InDepth
Therapeutics Daily: Sep 25 2009 4:22AM Matching: coronary circulation ... collateral blood flow. • 7465766- Hydroxyphenyl cross-linked macromolecular ...
http://www.bioportfolio.com/indepth/Coronary_Circulation.pdf...

BioPortfolio - Cardiovascular Consultants - Profile
Computed Tomography angiographic demonstration of collateral circulation in ... Therapeutics Corporation. (Nasdaq: UTHR) today announced its results of ...
http://www.bioportfolio.com/biocorporate/20542-Cardiovascula...

BioPortfolio - Popliteal Artery - InDepth
22 Sep 2009 ... 7108982- Diagnostics and the therapeutics for macular degeneration ... collateral blood flow. • 7473262- Methods and devices for blood ...
http://www.bioportfolio.com/indepth/Popliteal_Artery.pdf...

BioPortfolio - Global Health Economics & Outcomes Research - Profile
'Wellbeing': A collateral casualty of modernity? In the now vast empirical and theoretical ... Orexigen Therapeutics,. Inc. -- There was no evidence of ...
http://www.bioportfolio.com/biocorporate/23579-Global+Health...

BioPortfolio - Chondroitinases And Chondroitin Lyases - InDepth
... distribution of sulfated glycosaminoglycans in human medial collateral ligament: .... Therapeutics Daily: Oct 15 2009 2:57PM Matching: chondroitin ...
http://www.bioportfolio.com/indepth/Chondroitinases_And_Chon...

Results from other life science and pharmaceutical sites:

BioSpace - Collateral Therapeutics Inc. News, Search Jobs, Events
Collateral Therapeutics Inc. 11622 El Camino Real San Diego California 92130 U.S.A.. Phone: 858-794-3400 Fax: 858-794-3444 ...
http://www.biospace.com/company_profile.aspx?CompanyId=3386...

Collateral Therapeutics, Inc. Company Profile - Yahoo! Finance
No collateral damage here. Collateral Therapeutics, a subsidiary of Schering AG, develops gene therapies to treat various cardiovascular diseases as an ...
http://biz.yahoo.com/ic/56/56944.html...

FGF-4 gene therapy GENERX--Collateral Therapeutics.
Collateral Therapeutics and Schering AG in Germany are developing a gene therapy product, GENERX for coronary artery disease. ...
http://www.ncbi.nlm.nih.gov/pubmed/11909005...

Of Mice and Men: Essential Considerations in the Translation of ...
Variability of collateral flow across species, strains, and individuals, however , will ultimately determine the effect of collateral therapeutics. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27...

Collateral therapeutics for cerebral ischemia.
Although specific collateral therapeutics are unrealized, insight may be gleaned from subtle details of prior stroke studies. Future advances will result ...
http://www.ncbi.nlm.nih.gov/pubmed/15853567...

Halozyme Therapeutics - Board of Directors
His research and clinical work led to the founding of two successful biotechnology companies: Gensia, Inc., and Collateral Therapeutics, Inc. He also
...
http://www.halozyme.com/aboutus_board_of_directors.php...

Of mice and men: essential considerations in the translation of ...
Of mice and men: essential considerations in the translation of collateral therapeutics. Liebeskind DS. Publication Types: Comment; Letter. Mesh Terms: ...
http://www.ncbi.nlm.nih.gov/pubmed/18845798...

Study Indicates That FGF-4 Gene Therapy Is Useful in the Treatment ...
Dr. Hammond and his colleagues at Collateral Therapeutics, the Veteran's Affairs Medical Center, and University of California, San Diego, examined whether ...
http://www.medscape.com/viewarticle/411752...

Impact of collateral flow on tissue fate in acute ischaemic stroke
Infarct growth may be minimised with the use of collateral therapeutic strategies, particularly in the setting of persistent arterial occlusion despite
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702489/...

PeriCor Therapeutics Elects Robert L. Engler, M.D. To Boa ...
He was also co-founder of Collateral Therapeutics (subsequently sold to Schering AG) and served as a Director from 1995 to 2000 and as Vice President, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=23544...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.